

Please try another search
Biotechnology stocks have traded basically sideways since the start of 2023.
In the face of higher rates, stronger US dollar, inflation, FDA approvals and busts, and an emerging winter season, the iShares Biotechnology ETF (NASDAQ:IBB) has a serenity to it that appears drug-induced if you will.
Of the top 10 holdings, Regeneron (NASDAQ:REGN) is the big winner as of right now, while Biogen is under pressure. Note-would keep your eyes on a potential bottoming pattern in BIIB.
Furthermore, and even more interesting, is that the ETF does not really reflect the big movers. Rather, IBB is holding as a result but not flying.
Is it time to buy IBB?
On the Daily chart, what is not shown here is the July 6-month calendar range low at 124.11.
Only once has IBB traded below that level in 2023 in March after the bank mini-crisis.
Hence, we feel good calling 124 the bottom of the trading range and risk point.
The top of the trading range of the July 6-month indicator is 130.50.
Again, IBB traded above that in early 2023, when it soared to 138.
However, since then, 130-132 has been resistance. We feel good calling that level the top of the trading range.
As far as other indicators, Real Motion looks like a double bottom from early July and now, although we would like to see more momentum.
On the weekly chart, we can say the same.
Our Leadership indicator shows IBB outperforming SPY on a daily timeframe but still underperforming on a weekly basis.
On the price, over 128 will pique our interest.
Bitcoin doesn't have earnings, but these companies benefit from its rise. After breaching the $40,000 resistance on December 3rd, Bitcoin (BTC) is up 25% over the month, now...
Emini daily chart The S&P 500 Futures rallied yesterday, testing Wednesday’s high. The moving average is getting closer to the current price. This increases the odds that the...
Semiconductor giant Broadcom provided a revenue forecast for the year that fell short of Wall Street estimates The company cited subdued enterprise spending and intensified...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.